Deadline Approaching: Revance Therapeutics, Inc. (RVNC) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming March 4, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Revance Therapeutics, Inc. (“Revance” or the “Company”) RVNC securities between February 29, 2024 and …